WO2004082539A1 - Intragastric catheter - Google Patents

Intragastric catheter Download PDF

Info

Publication number
WO2004082539A1
WO2004082539A1 PCT/US2004/008049 US2004008049W WO2004082539A1 WO 2004082539 A1 WO2004082539 A1 WO 2004082539A1 US 2004008049 W US2004008049 W US 2004008049W WO 2004082539 A1 WO2004082539 A1 WO 2004082539A1
Authority
WO
WIPO (PCT)
Prior art keywords
bladder
tubules
stomach
intragastric catheter
neck
Prior art date
Application number
PCT/US2004/008049
Other languages
French (fr)
Other versions
WO2004082539A9 (en
Inventor
Rebecca Delegge
Original Assignee
Rebecca Delegge
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rebecca Delegge filed Critical Rebecca Delegge
Priority to DE602004015743T priority Critical patent/DE602004015743D1/en
Priority to JP2006507245A priority patent/JP2006520643A/en
Priority to EP04757520A priority patent/EP1603496B1/en
Priority to CA2517430A priority patent/CA2517430C/en
Publication of WO2004082539A1 publication Critical patent/WO2004082539A1/en
Publication of WO2004082539A9 publication Critical patent/WO2004082539A9/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013—Implantable devices or invasive measures
    • A61F5/003—Implantable devices or invasive measures inflatable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013—Implantable devices or invasive measures
    • A61F5/0036—Intragastrical devices
    • A61F5/004—Intragastrical devices remotely adjustable

Definitions

  • This invention relates to medical devices generally, and is more specifically related to an intragastric catheter that is useful in the treatment of obesity.
  • Morbid obesity is a major medical problem affecting millions of people. Many serious health problems are associated with morbid obesity, including hypertension, hyperlipidemia, exacerbation of diabetes mellitus, heart disease, degenerative arthritis, and Pickwickian syndrome, certain types of cancer, gallstones, varicose veins, thromboembolism and hernias. Additionally, morbid obesity can lead to psychosocial difficulties such as depression, loss of self-esteem and decreased employability.
  • An intragastric catheter provides satiety due to its presence in the stomach cavity. Tactile sensation by a plurality of fingers that extend from the device provides satiety. Normal peristaltic action upon the device provides movement of the fingers relative to the stomach wall, reducing the likelihood of ulceration or necrosis.
  • the structure of the intragastric catheter reduces the level of precision required in placement of the device, and the potential for blockage of conduits to and from the stomach by the device is reduced.
  • Figure 1 is a perspective view of the intragastric catheter.
  • Figure 2 is a sectioned view of the intragastric catheter, taken essentially along line 2-2 of Figure 1.
  • Figure 3 is a side elevation of an intragastric catheter in the deflated state and positioned within a user's stomach.
  • Figure 4 is a side elevation of an intragastric catheter in the inflated state and positioned within a user's stomach.
  • Figure 5 is a side elevation of an intragastric catheter in the inflated state and positioned within a user's stomach.
  • the intragastric catheter comprises a bladder 2.
  • a plurality of finger-like tubules 3 extend from various locations on the lower surface of the bladder.
  • a neck 4 connects a bolster to the bladder, and an external tube 6 extends from the internal bolster 8.
  • External bolster 9 assists in holding the device in place within the stomach.
  • the bladder contains a fluid 10.
  • the fluid may be a gas, a liquid, or a gel, or a mixture thereof, or a combination thereof.
  • the fluid is provided to the bladder through external tube 6. Increasing or decreasing the volume and pressure of fluid that is present in the chamber variably inflates the bladder.
  • the finger-like tubules are hollow, with the hollow space in the tubules communicating with the bladder to provide for a transfer of fluid. Accordingly, as the bladder is filled with fluid, the fluid flows into tubules, providing additional rigidity for the tubules, according to the volume and pressure of the fluid that is present in the chamber.
  • the chamber acts as a reservoir to supply fluid to the tubules.
  • the tubules are flexible, and are capable of a deformation relative to the bladder. Particularly at the point of attachment of the tubules to the bladder, the tubules may be displaced relative to the bladder.
  • the ends of the tubules that are opposite the bladder are dynamic. Movement of the tubules from peristaltic action provides a tactile sensation against the wall of the stomach, which provides satiety.
  • the tubules may be variably inflated by the device as required, to provide the desired tactile stimulation. If the tubules are substantially deflated, so that they are flaccid, as shown in Figure 3, then little tactile stimulation will occur.
  • the tubules have an enlarged end 16 that increases tactile stimulation.
  • the enlarged end has a recess that is centrally disposed within the end. This recess in the end of the tubules helps reduce constant contact of the end of the tubules with the stomach wall by reducing the amount of surface area that comes in contact with the stomach wall.
  • the neck 4 of the device is deformable, which insures proper orientation of the device relative to the stomach.
  • Figure 5. The bolster 8 is adjacent to the stomach wall 12, while the neck allows the remainder of the device to bend relative to the bolster. Accordingly, if the device is positioned by a PEG procedure, and placement of the device is not optimal, the device deforms relative to bolster by means of the neck, so that the tubules contact the stomach wall. For example, if the placement is too high relative to optimal placement, the neck bends to allow the device to enter the relatively lower part of the stomach.
  • Tubules 22 may be used to orient the device upon placement. As shown, tubules 22 from a higher point of the bladder when the device is positioned as in Figure 1. Tubules 22 extend from the bladder and opposite each other, and are generally horizontally when inflated and when the device is positioned as shown in Figure 1. These longer tubules help position the device. They are positioned by peristalsis and/or at placement so as to find the long axis of the stomach. If they are placed on the short axis, the stomach will move them to the position of least resistance.
  • a valve is present where the tubule joins the bladder.
  • the valve allows the tubule to be filled with fluid, but prevents fluid from returning to the chamber. In case of a leak in a particular tubule, the fluid will leak into the stomach from that tubule and it will become deflated. However, it is not necessary to replace the entire catheter as a result of the deflation of one, or a few, of the tubules, since the remainder of the device will remain inflated.
  • the valves could be positioned within the tubules, near the end of the tubule that joins the bladder, or the valves could be positioned within the bladder near the entrance to the tubules.
  • a diaphragm 22 is present within the bladder.
  • the fluid pressure in the bladder is increased, the liquid pressure on the opposite side the diaphragm is increased, and the pressure and volume within the tubules is increased.
  • handling and pressurizing a liquid or gel is more difficult for the patient, than is the application of air pressure. The patient may easily apply pressure to the device using an air pump, whereas attempting to pressurize a liquid or gel by the insertion of additional liquid or gel material under pressure is more difficult.
  • the device may be constructed of suitable materials that will inflate or deflate when filled with a fluid.
  • the device could be constructed of medical grade polyethylene terephthalate (PET). PET allows the device to have deformation characteristics similar to plastic storage bags that are commonly used in the kitchen, making it a suitable candidate for replacement by means of a percutaneous endoscopic gastrostomy (PEG) procedure as described herein.
  • PET allows the device to have deformation characteristics similar to plastic storage bags that are commonly used in the kitchen, making it a suitable candidate for replacement by means of a percutaneous endoscopic gastrostomy (PEG) procedure as described herein.
  • PEG percutaneous endoscopic gastrostomy
  • the tubules may be formed of two or more plies of material. For example, a 2-ply tubule will have better resistant to breakage or puncture than will a single ply tubule.
  • the intragastric catheter of the present invention may be introduced through the mouth, subsequently traveling through the esophagus and into the stomach.
  • the abdominal wall is punctured, and a guide wire is inserted from the outside into the fundus of the stomach.
  • the endoscope is grasped with the guide wire, and one end of the guide wire is extracted by pulling the endoscope out of the mouth while the other end of the guide wire remains outside of the abdomen.
  • the intragastric catheter is placed through the abdominal wall by attaching the intragastric catheter to the guide wire extended out of the patient's mouth and pulling on the other end of the guide wire until the intragastric catheter is pulled through the puncture opening in the abdominal wall.
  • the placed intragastric catheter is secured on the stomach wall with the bolster.
  • Figures 3 through 5 show the intragastric catheter as it is positioned intragastrically within the obese person.
  • the device is in position in the stomach, but is not inflated.
  • Figure 4 shows the device positioned in the stomach as in Figure 3, and after inflation of the tubules.
  • Figure 5 shows the device as inflated and in the stomach, with the neck 4 of the device providing deformation of the device within the stomach.
  • the intragastric catheter has multiple finger like tubules that are subject to the peristalsis within the stomach, which causes movement of the tubules, and prevents pressure from being constantly applied on one surface of the stomach. Gastric erosion is thereby prevented.
  • the tactile sensation provided by the finger like tubules against the stomach provides satiety, and suppresses the patient's appetite

Abstract

An intragastric catheter provides satiety due to its presence in the stomach cavity. Tactile sensation by a plurality of fingers that extend from the device provides satiety. Normal peristaltic action upon the device provides movement of the fingers relative to the stomach wall, reducing the likelihood of ulceration or necrosis. The structure of the intragastric catheter reduces the level of precision required in placement of the device, and the likelihood of blockage of conduits to and from the stomach by the device is reduced.

Description

FIELD OF THE INVENTION
This invention relates to medical devices generally, and is more specifically related to an intragastric catheter that is useful in the treatment of obesity.
BACKGROUND OF THE INVENTION
Morbid obesity is a major medical problem affecting millions of people. Many serious health problems are associated with morbid obesity, including hypertension, hyperlipidemia, exacerbation of diabetes mellitus, heart disease, degenerative arthritis, and Pickwickian syndrome, certain types of cancer, gallstones, varicose veins, thromboembolism and hernias. Additionally, morbid obesity can lead to psychosocial difficulties such as depression, loss of self-esteem and decreased employability.
Attempts to induce weight loss in morbidly obese patients have been largely unsuccessful. Diet, exercise and behavioral modification are usually not effective in the long term because the morbidly obese patient does not maintain adherence to these programs. Further, such programs may risk further damage to the patient's health. The long term use of pharmaceuticals in bariatric medicine is also problematic. Use of pharmaceutical agents may lead to addiction, undesired side effects, and/or loss of potency due to drug tolerance. Surgical procedures that have been applied include jejunoileal or gastric bypass surgery, gastroplasty and gastric stapling and oral surgical procedures such as wiring shut the patient's jaws to reduce food intake. These procedures are effective in producing weight loss, but are invasive, with associated risks and recovery times, as well as being expensive and often ineffective over the long term. Various intragastric inflatable balloon devices have been heretofore used.
These devices occupy the stomach cavity, thereby reducing its volume, and providing satiety. Problems associated with these devices include undesired deflation, requiring surgical removal, and ulceration or necrosis created by constant pressure of the device on the stomach wall and gastric outlet obstruction. Placement of devices by a percutaneous endoscopic gastrostomy (PEG) procedures, while less expensive than surgical procedures, are less precise. Balloon type intragastric catheters positioned by PEG procedures, as described in De Hoyos Garza, United States Patent 6,454,785, may block only a portion of the stomach, or they may block entry to the stomach from the esophagus if the device is not precisely positioned.
SUMMARY OF THE PRESENT INVENTION An intragastric catheter provides satiety due to its presence in the stomach cavity. Tactile sensation by a plurality of fingers that extend from the device provides satiety. Normal peristaltic action upon the device provides movement of the fingers relative to the stomach wall, reducing the likelihood of ulceration or necrosis. The structure of the intragastric catheter reduces the level of precision required in placement of the device, and the potential for blockage of conduits to and from the stomach by the device is reduced.
DESCRIPTION OF THE DRAWINGS Figure 1 is a perspective view of the intragastric catheter. Figure 2 is a sectioned view of the intragastric catheter, taken essentially along line 2-2 of Figure 1.
Figure 3 is a side elevation of an intragastric catheter in the deflated state and positioned within a user's stomach.
Figure 4 is a side elevation of an intragastric catheter in the inflated state and positioned within a user's stomach.
Figure 5 is a side elevation of an intragastric catheter in the inflated state and positioned within a user's stomach.
DESCRIPTION OF THE PREFERRED EMBODIMENTS Referring now to Figure 1, the intragastric catheter comprises a bladder 2. A plurality of finger-like tubules 3 extend from various locations on the lower surface of the bladder. In the embodiment as shown, a neck 4 connects a bolster to the bladder, and an external tube 6 extends from the internal bolster 8. External bolster 9 assists in holding the device in place within the stomach. In the preferred embodiment, the bladder contains a fluid 10. The fluid may be a gas, a liquid, or a gel, or a mixture thereof, or a combination thereof. The fluid is provided to the bladder through external tube 6. Increasing or decreasing the volume and pressure of fluid that is present in the chamber variably inflates the bladder. In the preferred embodiment, the finger-like tubules are hollow, with the hollow space in the tubules communicating with the bladder to provide for a transfer of fluid. Accordingly, as the bladder is filled with fluid, the fluid flows into tubules, providing additional rigidity for the tubules, according to the volume and pressure of the fluid that is present in the chamber. The chamber acts as a reservoir to supply fluid to the tubules.
The tubules are flexible, and are capable of a deformation relative to the bladder. Particularly at the point of attachment of the tubules to the bladder, the tubules may be displaced relative to the bladder. As normal peristaltic action of the stomach 14 causes the device to be moved about within the stomach, the ends of the tubules that are opposite the bladder are dynamic. Movement of the tubules from peristaltic action provides a tactile sensation against the wall of the stomach, which provides satiety. The tubules may be variably inflated by the device as required, to provide the desired tactile stimulation. If the tubules are substantially deflated, so that they are flaccid, as shown in Figure 3, then little tactile stimulation will occur. On the other hand, over inflation may result in insufficient movement of the tubules. Movement of the tubules due to peristaltic action prevents the tubules from constantly contacting a single point of the stomach wall, thereby reducing necrosis or ulceration due to constant contact of the tubules with the stomach wall. In the preferred embodiment, the tubules have an enlarged end 16 that increases tactile stimulation. In the particular embodiment shown in the drawing figures, the enlarged end has a recess that is centrally disposed within the end. This recess in the end of the tubules helps reduce constant contact of the end of the tubules with the stomach wall by reducing the amount of surface area that comes in contact with the stomach wall.
The neck 4 of the device is deformable, which insures proper orientation of the device relative to the stomach. Figure 5. The bolster 8 is adjacent to the stomach wall 12, while the neck allows the remainder of the device to bend relative to the bolster. Accordingly, if the device is positioned by a PEG procedure, and placement of the device is not optimal, the device deforms relative to bolster by means of the neck, so that the tubules contact the stomach wall. For example, if the placement is too high relative to optimal placement, the neck bends to allow the device to enter the relatively lower part of the stomach. The use of the finger like tubules, rather than a massive object like a balloon, prevents blockage of the entry 18 or exits 20 of the stomach.
Longer tubules 22 may be used to orient the device upon placement. As shown, tubules 22 from a higher point of the bladder when the device is positioned as in Figure 1. Tubules 22 extend from the bladder and opposite each other, and are generally horizontally when inflated and when the device is positioned as shown in Figure 1. These longer tubules help position the device. They are positioned by peristalsis and/or at placement so as to find the long axis of the stomach. If they are placed on the short axis, the stomach will move them to the position of least resistance.
• In one embodiment of the invention, a valve is present where the tubule joins the bladder. The valve allows the tubule to be filled with fluid, but prevents fluid from returning to the chamber. In case of a leak in a particular tubule, the fluid will leak into the stomach from that tubule and it will become deflated. However, it is not necessary to replace the entire catheter as a result of the deflation of one, or a few, of the tubules, since the remainder of the device will remain inflated. The valves could be positioned within the tubules, near the end of the tubule that joins the bladder, or the valves could be positioned within the bladder near the entrance to the tubules. In one embodiment of the bladder, a diaphragm 22 is present within the bladder. A fluid 24, which is preferred to be a liquid, a gel, or a mixture thereof, is present on one side of the diaphragm. This side of the diaphragm communicates with the tubules. A fluid 10 under pressure, which could be air, is present on the other side of the diaphragm, and is provided through the external tube. As the fluid pressure in the bladder is increased, the liquid pressure on the opposite side the diaphragm is increased, and the pressure and volume within the tubules is increased. While the use of the liquid or a gel to fill the tubules is preferred, handling and pressurizing a liquid or gel is more difficult for the patient, than is the application of air pressure. The patient may easily apply pressure to the device using an air pump, whereas attempting to pressurize a liquid or gel by the insertion of additional liquid or gel material under pressure is more difficult.
The device may be constructed of suitable materials that will inflate or deflate when filled with a fluid. In a preferred embodiment, the device could be constructed of medical grade polyethylene terephthalate (PET). PET allows the device to have deformation characteristics similar to plastic storage bags that are commonly used in the kitchen, making it a suitable candidate for replacement by means of a percutaneous endoscopic gastrostomy (PEG) procedure as described herein. The tubules may be formed of two or more plies of material. For example, a 2-ply tubule will have better resistant to breakage or puncture than will a single ply tubule.
The intragastric catheter of the present invention may be introduced through the mouth, subsequently traveling through the esophagus and into the stomach. The abdominal wall is punctured, and a guide wire is inserted from the outside into the fundus of the stomach. The endoscope is grasped with the guide wire, and one end of the guide wire is extracted by pulling the endoscope out of the mouth while the other end of the guide wire remains outside of the abdomen. The intragastric catheter is placed through the abdominal wall by attaching the intragastric catheter to the guide wire extended out of the patient's mouth and pulling on the other end of the guide wire until the intragastric catheter is pulled through the puncture opening in the abdominal wall. The placed intragastric catheter is secured on the stomach wall with the bolster.
Figures 3 through 5 show the intragastric catheter as it is positioned intragastrically within the obese person. As shown in Figure 3, the device is in position in the stomach, but is not inflated. Figure 4 shows the device positioned in the stomach as in Figure 3, and after inflation of the tubules. Figure 5 shows the device as inflated and in the stomach, with the neck 4 of the device providing deformation of the device within the stomach. The intragastric catheter has multiple finger like tubules that are subject to the peristalsis within the stomach, which causes movement of the tubules, and prevents pressure from being constantly applied on one surface of the stomach. Gastric erosion is thereby prevented. The tactile sensation provided by the finger like tubules against the stomach provides satiety, and suppresses the patient's appetite

Claims

What is claimed is:
1. An intragastric catheter, comprising: a) a bladder; and b) a plurality of flexible tubules extending from said bladder that are deformable relative to said bladder upon the application of peristaltic action of a human stomach; wherein each of said bladder and said multiplicity of flexible tubules is positioned intragastrically within a user.
2. An intragastric catheter, as described in Claim 1, wherein said bladder and said tubules are inflatable.
'3. An intragastric catheter, as described in Claim 2, wherein said intragastric catheter further comprises a valve that communicates with said bladder.
4. An intragastric catheter as described in Claim 1, wherein said intragastric catheter further comprises a bolster and a neck, wherein said neck connects said bladder to said bolster.
5. An intragastric catheter as described in Claim 2, wherein said bladder has a fluid therein, and wherein each of said multiplicity of tubules communicates with said bladder and said multiplicity of tubules are formed to receive a portion of said fluid from said bladder.
6. An intragastric catheter as described in Claim 2, wherein each of said multiplicity of tubules has a valve therein.
7. An intragastric catheter as described in Claim 1, wherein each of said multiplicity of tubules has an enlarged end that is opposite an end of each of said multiplicity of tubules that is adjacent to said bladder.
8. An intragastric catheter as described in Claim 1, wherein said intragastric catheter further comprises a neck that is positioned between said bladder and a stomach wall, wherein said neck is deformable relative to said stomach wall and wherein said neck deforms to position said bladder and said tubules within a stomach.
9. An intragastric catheter as described in Claim 4, wherein said intragastric catheter further comprises a bolster and a neck, wherein said neck connects said bladder to said bolster, and wherein said neck is deformable relative to said bolster and said bladder, and wherein said neck deforms to position said bladder and said tubules within a stomach.
PCT/US2004/008049 2003-03-17 2004-03-17 Intragastric catheter WO2004082539A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DE602004015743T DE602004015743D1 (en) 2003-03-17 2004-03-17 INTRAGASTRIC CATHETER
JP2006507245A JP2006520643A (en) 2003-03-17 2004-03-17 Intragastric catheter
EP04757520A EP1603496B1 (en) 2003-03-17 2004-03-17 Intragastric catheter
CA2517430A CA2517430C (en) 2003-03-17 2004-03-17 Intragastric catheter

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/390,947 US7291160B2 (en) 2003-03-17 2003-03-17 Intragastric catheter
US10/390,947 2003-03-17

Publications (2)

Publication Number Publication Date
WO2004082539A1 true WO2004082539A1 (en) 2004-09-30
WO2004082539A9 WO2004082539A9 (en) 2005-04-14

Family

ID=32987603

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/008049 WO2004082539A1 (en) 2003-03-17 2004-03-17 Intragastric catheter

Country Status (7)

Country Link
US (3) US7291160B2 (en)
EP (1) EP1603496B1 (en)
JP (1) JP2006520643A (en)
AT (1) ATE404136T1 (en)
CA (1) CA2517430C (en)
DE (1) DE602004015743D1 (en)
WO (1) WO2004082539A1 (en)

Families Citing this family (114)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE410123T1 (en) * 2001-05-17 2008-10-15 Wilson Cook Medical Inc INTRAGASTRAL DEVICE FOR TREATING OBESITY
US6675809B2 (en) 2001-08-27 2004-01-13 Richard S. Stack Satiation devices and methods
US7097665B2 (en) 2003-01-16 2006-08-29 Synecor, Llc Positioning tools and methods for implanting medical devices
CN101810521B (en) 2001-08-27 2015-05-13 辛尼科有限责任公司 Satiation devices and methods
US7146984B2 (en) * 2002-04-08 2006-12-12 Synecor, Llc Method and apparatus for modifying the exit orifice of a satiation pouch
US8845672B2 (en) 2002-05-09 2014-09-30 Reshape Medical, Inc. Balloon system and methods for treating obesity
US20040143342A1 (en) 2003-01-16 2004-07-22 Stack Richard S. Satiation pouches and methods of use
US20090259236A2 (en) 2003-07-28 2009-10-15 Baronova, Inc. Gastric retaining devices and methods
US9498366B2 (en) 2003-07-28 2016-11-22 Baronova, Inc. Devices and methods for pyloric anchoring
US9700450B2 (en) 2003-07-28 2017-07-11 Baronova, Inc. Devices and methods for gastrointestinal stimulation
AU2004266574B2 (en) 2003-08-13 2010-11-04 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Compressive device for percutaneous treatment of obesity
US8206456B2 (en) 2003-10-10 2012-06-26 Barosense, Inc. Restrictive and/or obstructive implant system for inducing weight loss
US20050247320A1 (en) 2003-10-10 2005-11-10 Stack Richard S Devices and methods for retaining a gastro-esophageal implant
US8585771B2 (en) * 2004-02-26 2013-11-19 Endosphere, Inc. Methods and devices to curb appetite and/or to reduce food intake
US8147561B2 (en) 2004-02-26 2012-04-03 Endosphere, Inc. Methods and devices to curb appetite and/or reduce food intake
US7931693B2 (en) * 2004-02-26 2011-04-26 Endosphere, Inc. Method and apparatus for reducing obesity
US20060142790A1 (en) * 2004-03-23 2006-06-29 Michael Gertner Methods and devices to facilitate connections between body lumens
US7255675B2 (en) 2004-03-23 2007-08-14 Michael Gertner Devices and methods to treat a patient
US20070233170A1 (en) * 2004-03-23 2007-10-04 Michael Gertner Extragastric Balloon
WO2007067206A2 (en) * 2005-05-10 2007-06-14 Michael Gertner Obesity treatment systems
US7946976B2 (en) 2004-03-23 2011-05-24 Michael Gertner Methods and devices for the surgical creation of satiety and biofeedback pathways
WO2006049725A2 (en) * 2004-03-23 2006-05-11 Minimus Surgical Systems Surgical systems and devices to enhance gastric restriction therapies
US20060195139A1 (en) * 2004-03-23 2006-08-31 Michael Gertner Extragastric devices and methods for gastroplasty
EP1740132B1 (en) 2004-04-26 2014-12-31 Synecor, LLC Restrictive and/or obstructive implant for inducing weight loss
US8066780B2 (en) * 2004-05-03 2011-11-29 Fulfillium, Inc. Methods for gastric volume control
TWI280383B (en) * 2004-06-29 2007-05-01 Japan Ae Power Systems Corp Partial discharge detecting sensor, and detecting device, and gas insulated electric apparatus provided with a partial discharge detecting sensor
US9456915B2 (en) 2004-11-19 2016-10-04 Fulfilium, Inc. Methods, devices, and systems for obesity treatment
US8070807B2 (en) * 2004-11-19 2011-12-06 Fulfillium, Inc. Wireless breach detection
US20060142731A1 (en) * 2004-12-27 2006-06-29 Jeffrey Brooks Floating gastro-intestinal anchor
US8403952B2 (en) * 2004-12-27 2013-03-26 Spatz-Fgia, Inc. Floating gastrointestinal anchor
WO2014082044A1 (en) 2012-11-26 2014-05-30 Spatz Fgia, Inc. System and methods for internalization of components of an adjustable intragastric balloon
US9974680B2 (en) 2004-12-27 2018-05-22 Spatz Fgia, Inc. System and methods for internalization of external components of adjustable intragastric balloon
US9345604B2 (en) * 2005-05-02 2016-05-24 Almuhannad Alfrhan Percutaneous intragastric balloon device and method
WO2006122019A2 (en) * 2005-05-09 2006-11-16 Wilson-Cook Medical, Inc. Intragastric device for treating obesity
CA2611477C (en) 2005-06-10 2012-01-17 Wilson-Cook Medical, Inc. Cautery catheter
US8021384B2 (en) * 2005-07-26 2011-09-20 Ram Weiss Extending intrabody capsule
WO2007013059A2 (en) * 2005-07-26 2007-02-01 Ram Weiss Extending intrabody capsule
US9055942B2 (en) 2005-10-03 2015-06-16 Boston Scienctific Scimed, Inc. Endoscopic plication devices and methods
US20080190989A1 (en) * 2005-10-03 2008-08-14 Crews Samuel T Endoscopic plication device and method
US20070100369A1 (en) * 2005-10-31 2007-05-03 Cragg Andrew H Intragastric space filler
US20070100368A1 (en) 2005-10-31 2007-05-03 Quijano Rodolfo C Intragastric space filler
WO2007076021A2 (en) 2005-12-22 2007-07-05 Wilson-Cook Medical Inc. Intragastric bag for treating obesity
JP2009531122A (en) * 2006-03-28 2009-09-03 スパツフジア インコーポレイティド Floating gastrointestinal anchor
US8342183B2 (en) 2006-04-19 2013-01-01 Vibrynt, Inc. Devices and methods for treatment of obesity
US8398668B2 (en) * 2006-04-19 2013-03-19 Vibrynt, Inc. Devices and methods for treatment of obesity
US8585733B2 (en) 2006-04-19 2013-11-19 Vibrynt, Inc Devices, tools and methods for performing minimally invasive abdominal surgical procedures
US20090281498A1 (en) * 2006-04-19 2009-11-12 Acosta Pablo G Devices, system and methods for minimally invasive abdominal surgical procedures
US20090287227A1 (en) * 2006-04-19 2009-11-19 Newell Matthew B Minimally invasive ,methods for implanting obesity treatment devices
US7976554B2 (en) 2006-04-19 2011-07-12 Vibrynt, Inc. Devices, tools and methods for performing minimally invasive abdominal surgical procedures
US8187297B2 (en) 2006-04-19 2012-05-29 Vibsynt, Inc. Devices and methods for treatment of obesity
US8556925B2 (en) 2007-10-11 2013-10-15 Vibrynt, Inc. Devices and methods for treatment of obesity
US8070768B2 (en) 2006-04-19 2011-12-06 Vibrynt, Inc. Devices and methods for treatment of obesity
US9060835B2 (en) * 2006-05-26 2015-06-23 Endosphere, Inc. Conformationally-stabilized intraluminal device for medical applications
US20080109027A1 (en) * 2006-08-01 2008-05-08 Fulfillium, Inc. Method and system for gastric volume control
US8109895B2 (en) 2006-09-02 2012-02-07 Barosense, Inc. Intestinal sleeves and associated deployment systems and methods
US20090125040A1 (en) * 2006-09-13 2009-05-14 Hambly Pablo R Tissue acquisition devices and methods
WO2008033474A2 (en) 2006-09-15 2008-03-20 Synecor, Llc System for anchoring stomach implant
US9326877B2 (en) * 2006-09-29 2016-05-03 Apollo Endosurgery, Inc. Apparatus and method for intragastric balloon with in situ adjustment means
WO2008085290A2 (en) * 2006-12-28 2008-07-17 Vibrynt, Inc. Devices and methods for treatment of obesity
AU2008220432A1 (en) * 2007-02-26 2008-09-04 Duocure, Inc. Spray administration of compositions including active agents such as peptides to the gastrointestinal tract
US20090082644A1 (en) * 2007-03-15 2009-03-26 Jiayi Li Devices, Systems, Kits and Methods for Treatment of Obesity
WO2008132745A2 (en) * 2007-04-30 2008-11-06 Spatz Fgia, Inc. Non-endoscopic insertion and removal of a device
US8007507B2 (en) 2007-05-10 2011-08-30 Cook Medical Technologies Llc Intragastric bag apparatus and method of delivery for treating obesity
WO2008141288A1 (en) * 2007-05-12 2008-11-20 Barosense, Inc. Devices and methods for stomach partitioning
US20110137227A1 (en) 2007-07-16 2011-06-09 Mckinley James T Methods and devices for delivering or delaying lipids within a duodenum
US20090030284A1 (en) 2007-07-18 2009-01-29 David Cole Overtube introducer for use in endoscopic bariatric surgery
EP2178447B1 (en) 2007-07-18 2017-10-25 Boston Scientific Scimed, Inc. Endoscopic implant system and method
US20090149879A1 (en) * 2007-12-10 2009-06-11 Dillon Travis E Dynamic volume displacement weight loss device
US7883524B2 (en) 2007-12-21 2011-02-08 Wilson-Cook Medical Inc. Method of delivering an intragastric device for treating obesity
US8016851B2 (en) 2007-12-27 2011-09-13 Cook Medical Technologies Llc Delivery system and method of delivery for treating obesity
US20090171383A1 (en) * 2007-12-31 2009-07-02 David Cole Gastric space occupier systems and methods of use
US8020741B2 (en) 2008-03-18 2011-09-20 Barosense, Inc. Endoscopic stapling devices and methods
US7934631B2 (en) 2008-11-10 2011-05-03 Barosense, Inc. Multi-fire stapling systems and methods for delivering arrays of staples
WO2010075482A2 (en) * 2008-12-27 2010-07-01 John Hancock High specific gravity intragastric device
US9278019B2 (en) 2009-04-03 2016-03-08 Metamodix, Inc Anchors and methods for intestinal bypass sleeves
WO2010115011A1 (en) 2009-04-03 2010-10-07 Metamodix, Inc. Modular gastrointestinal prostheses
US9173760B2 (en) 2009-04-03 2015-11-03 Metamodix, Inc. Delivery devices and methods for gastrointestinal implants
US8282598B2 (en) 2009-07-10 2012-10-09 Metamodix, Inc. External anchoring configurations for modular gastrointestinal prostheses
US8702641B2 (en) 2009-04-03 2014-04-22 Metamodix, Inc. Gastrointestinal prostheses having partial bypass configurations
US20100276469A1 (en) * 2009-05-01 2010-11-04 Barosense, Inc. Plication tagging device and method
US8961539B2 (en) * 2009-05-04 2015-02-24 Boston Scientific Scimed, Inc. Endoscopic implant system and method
WO2011011743A2 (en) 2009-07-23 2011-01-27 Reshape Medical, Inc. Deflation and removal of implantable medical devices
WO2011045785A1 (en) * 2009-10-13 2011-04-21 Spatz Fgia, Inc. Balloon hydraulic and gaseous expansion system
CA2778590A1 (en) 2009-10-21 2011-04-28 Innovelle, Llc Bariatric device and method for weight loss
WO2011097636A1 (en) 2010-02-08 2011-08-11 Reshape Medical, Inc. Improved and enhanced aspiration processes and mechanisms for intragastric devices
WO2011106637A1 (en) 2010-02-25 2011-09-01 Reshape Medical, Inc. Improved and enhanced explant processes and mechanisms for intragastric devices
AU2011227357B2 (en) 2010-03-15 2015-04-02 Boston Scientific Scimed, Inc. Bariatric device and method for weight loss
US9629740B2 (en) 2010-04-06 2017-04-25 Reshape Medical, Inc. Inflation devices for intragastric devices with improved attachment and detachment and associated systems and methods
US9962275B2 (en) 2010-10-07 2018-05-08 Randy Louis Werneth Temporary gastric device (TGD) and method of use
US20120089170A1 (en) * 2010-10-11 2012-04-12 Allergan, Inc. Intragastric balloon geometries
EP2627291A2 (en) * 2010-10-11 2013-08-21 Allergan, Inc. Re-shaping intragastric implants
US9233016B2 (en) 2010-10-18 2016-01-12 Apollo Endosurgery, Inc. Elevating stomach stimulation device
US9463107B2 (en) * 2010-10-18 2016-10-11 Apollo Endosurgery, Inc. Variable size intragastric implant devices
WO2012054514A2 (en) 2010-10-18 2012-04-26 Allergan, Inc. Intragastric implants with duodenal anchors
WO2012054519A2 (en) 2010-10-18 2012-04-26 Allergan, Inc. Reactive intragastric implant devices
US8870966B2 (en) 2010-10-18 2014-10-28 Apollo Endosurgery, Inc. Intragastric balloon for treating obesity
US9498365B2 (en) 2010-10-19 2016-11-22 Apollo Endosurgery, Inc. Intragastric implants with multiple fluid chambers
US9198790B2 (en) * 2010-10-19 2015-12-01 Apollo Endosurgery, Inc. Upper stomach gastric implants
US20120095483A1 (en) 2010-10-19 2012-04-19 Allergan, Inc. Anchored non-piercing duodenal sleeve and delivery systems
US9095405B2 (en) 2010-10-19 2015-08-04 Apollo Endosurgery, Inc. Space-filling intragastric implants with fluid flow
US8864840B2 (en) 2010-10-19 2014-10-21 Apollo Endosurgery, Inc. Intragastric implants with collapsible frames
US9398969B2 (en) 2010-10-19 2016-07-26 Apollo Endosurgery, Inc. Upper stomach gastric implants
US8920447B2 (en) 2010-10-19 2014-12-30 Apollo Endosurgery, Inc. Articulated gastric implant clip
US8963708B2 (en) 2011-01-13 2015-02-24 Sensurtec, Inc. Breach detection in solid structures
BR112014010523A2 (en) 2011-11-01 2017-06-13 Endosphere Inc intragastric device and method of anchoring a treatment device within the stomach
US9314362B2 (en) 2012-01-08 2016-04-19 Vibrynt, Inc. Methods, instruments and devices for extragastric reduction of stomach volume
US8382775B1 (en) 2012-01-08 2013-02-26 Vibrynt, Inc. Methods, instruments and devices for extragastric reduction of stomach volume
AU2014207608A1 (en) 2013-01-15 2015-07-30 Metamodix, Inc. System and method for affecting intestinal microbial flora
US10245021B2 (en) 2013-10-08 2019-04-02 Applied Medical Technology, Inc Magnetic U-stitch device
US20150223956A1 (en) * 2014-02-12 2015-08-13 Children's National Medical Center Anchored non-spherical balloon for the treatment of obesity
US9687375B2 (en) 2015-03-17 2017-06-27 Shahriar Sedghi Magnetic satiety-inducing system
US9622897B1 (en) 2016-03-03 2017-04-18 Metamodix, Inc. Pyloric anchors and methods for intestinal bypass sleeves
US10751209B2 (en) 2016-05-19 2020-08-25 Metamodix, Inc. Pyloric anchor retrieval tools and methods
MX2019009497A (en) 2017-02-09 2020-01-30 Spatz FGIA Ltd Check valve with docking station for gastrointestinal balloon.

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234454A (en) * 1991-08-05 1993-08-10 Akron City Hospital Percutaneous intragastric balloon catheter and method for controlling body weight therewith
US5868141A (en) * 1997-05-14 1999-02-09 Ellias; Yakub A. Endoscopic stomach insert for treating obesity and method for use
WO2002071951A1 (en) * 2001-03-09 2002-09-19 Garza Alvarez Jose Rafael Intragastric balloon assembly

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980000007A1 (en) * 1978-06-02 1980-01-10 A Rockey Medical sleeve
US4648383A (en) * 1985-01-11 1987-03-10 Angelchik Jean P Peroral apparatus for morbid obesity treatment
CH668192A5 (en) * 1985-11-29 1988-12-15 Schneider Medintag Ag CATHETER FOR TREATING NARROW BODIES, FOR EXAMPLE IN A BLOOD VESSEL.
US4694827A (en) * 1986-01-14 1987-09-22 Weiner Brian C Inflatable gastric device for treating obesity and method of using the same
US4739758A (en) * 1986-05-19 1988-04-26 Criticare Systems, Inc. Apparatus for stomach cavity reduction
US4878495A (en) * 1987-05-15 1989-11-07 Joseph Grayzel Valvuloplasty device with satellite expansion means
US5954739A (en) * 1990-03-02 1999-09-21 General Surgical Innovations, Inc. Method of dissecting tissue layers
US5379759A (en) * 1991-02-04 1995-01-10 Sewell, Jr.; Frank K. Retractor for endoscopic surgery
US5653690A (en) * 1992-12-30 1997-08-05 Medtronic, Inc. Catheter having a balloon with retention enhancement
US5501667A (en) * 1994-03-15 1996-03-26 Cordis Corporation Perfusion balloon and method of use and manufacture
US5947924A (en) * 1996-09-13 1999-09-07 Angiorad, L.L.C. Dilatation/centering catheter used for the treatment of stenosis or other constriction in a bodily passageway and method thereof
US5725535A (en) * 1996-09-20 1998-03-10 Hegde; Anant V. Multiple balloon stent delivery catheter and method
US6013054A (en) * 1997-04-28 2000-01-11 Advanced Cardiovascular Systems, Inc. Multifurcated balloon catheter
US5993473A (en) * 1997-11-19 1999-11-30 Chan; Yung C. Expandable body device for the gastric cavity and method
US6017324A (en) * 1998-10-20 2000-01-25 Tu; Lily Chen Dilatation catheter having a bifurcated balloon
MXPA00001922A (en) * 2000-02-24 2002-03-08 De Hayos Garza Andres Percutaneous intra-gastric balloon catheter for obesity treatment.
US7033373B2 (en) * 2000-11-03 2006-04-25 Satiety, Inc. Method and device for use in minimally invasive placement of space-occupying intragastric devices
US6579301B1 (en) 2000-11-17 2003-06-17 Syntheon, Llc Intragastric balloon device adapted to be repeatedly varied in volume without external assistance
ATE410123T1 (en) 2001-05-17 2008-10-15 Wilson Cook Medical Inc INTRAGASTRAL DEVICE FOR TREATING OBESITY
US6627206B2 (en) 2001-07-25 2003-09-30 Greg A. Lloyd Method and apparatus for treating obesity and for delivering time-released medicaments
US6675809B2 (en) 2001-08-27 2004-01-13 Richard S. Stack Satiation devices and methods
US6755869B2 (en) 2001-11-09 2004-06-29 Boston Scientific Corporation Intragastric prosthesis for the treatment of morbid obesity
DE60328476D1 (en) * 2002-05-09 2009-09-03 Reshape Medical MEDICAL BALLOON SYSTEM FOR THE TREATMENT OF ADIPOSITAS
US6746460B2 (en) * 2002-08-07 2004-06-08 Satiety, Inc. Intra-gastric fastening devices
US7264631B2 (en) * 2002-09-16 2007-09-04 Scimed Life Systems, Inc. Devices and methods for AAA management
US7037344B2 (en) 2002-11-01 2006-05-02 Valentx, Inc. Apparatus and methods for treatment of morbid obesity
US20040133147A1 (en) 2002-11-06 2004-07-08 Woo Sang Hoon Intestinal bypass device to treat obesity
US7025791B2 (en) 2002-12-02 2006-04-11 Gi Dynamics, Inc. Bariatric sleeve
US20040143342A1 (en) 2003-01-16 2004-07-22 Stack Richard S. Satiation pouches and methods of use

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234454A (en) * 1991-08-05 1993-08-10 Akron City Hospital Percutaneous intragastric balloon catheter and method for controlling body weight therewith
US5868141A (en) * 1997-05-14 1999-02-09 Ellias; Yakub A. Endoscopic stomach insert for treating obesity and method for use
WO2002071951A1 (en) * 2001-03-09 2002-09-19 Garza Alvarez Jose Rafael Intragastric balloon assembly

Also Published As

Publication number Publication date
US20080071305A1 (en) 2008-03-20
US20040186503A1 (en) 2004-09-23
CA2517430A1 (en) 2004-09-30
CA2517430C (en) 2013-06-18
JP2006520643A (en) 2006-09-14
US7223277B2 (en) 2007-05-29
EP1603496B1 (en) 2008-08-13
US7883525B2 (en) 2011-02-08
US7291160B2 (en) 2007-11-06
WO2004082539A9 (en) 2005-04-14
ATE404136T1 (en) 2008-08-15
US20050033345A1 (en) 2005-02-10
EP1603496A1 (en) 2005-12-14
DE602004015743D1 (en) 2008-09-25

Similar Documents

Publication Publication Date Title
EP1603496B1 (en) Intragastric catheter
US6454785B2 (en) Percutaneous intragastric balloon catheter for the treatment of obesity
US5234454A (en) Percutaneous intragastric balloon catheter and method for controlling body weight therewith
US8870966B2 (en) Intragastric balloon for treating obesity
EP2629711B1 (en) Intragastric implants with multiple fluid chambers
EP2001401A2 (en) Medical device and method for controlling obesity
EP2629715B1 (en) Reactive intragastric implant devices
WO2007124167A2 (en) Feeding device and bolster apparatus and method for making the same
US20170065444A1 (en) Variable Size Intragastric Implant Devices
US20140025100A1 (en) Re-shaping intragastric implants
US20070038239A1 (en) Asymmetrically inflating flexi-tip gastroplasty calibration tube
WO2014055766A1 (en) Intragastric balloon for treating obesity
US20170333049A1 (en) Pyloric obstruction device with space-occupying device
WO2006022709A1 (en) Food extraction apparatus and method
AU2004243673A1 (en) Asymmetrically inflating flexi-tip gastroplasty calibration tube

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
COP Corrected version of pamphlet

Free format text: PAGE 1, DESCRIPTION, REPLACED BY NEW PAGE 1; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

WWE Wipo information: entry into national phase

Ref document number: 2517430

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2004757520

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2006507245

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2004757520

Country of ref document: EP